EAGLET-CS Pilot: Early General Anesthesia to Limit Experiences of Trauma During Cesarean Section-Pilot Study
| Registry | NCT07334418, acronym EAGLET-CS |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, other |
| Enrollment | 600 (Estimated) |
| Sponsor | University of Pennsylvania (Other) |
| Conditions | Cesarean Section, Delivery; Trauma |
| Interventions | General anesthetic, Intravenous anesthetic (Other) |
| Dates | start 2026-04-06, primary completion 2027-11-01 (estimated), completion 2027-11-01 (estimated), first posted 2026-01-12, last updated 2026-06-11 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cesarean Section All trials for Delivery; Trauma All trials of General anesthetic All trials of Intravenous anesthetic
Some patients who undergo cesarean section under spinal or epidural anesthesia can experience severe pain. Some patients who experience this kind of pain can experience symptoms of post-traumatic stress disorder (PTSD) after pregnancy. Currently, the two main options for treating this pain are general anesthesia (full medically induced unconsciousness) and using intravenous medications to reduce the pain and decrease anxiety. The EAGLET-CS Pilot is a pilot randomized trial that will test the feasibility of comparing the impact of these two options for preventing PTSD in a rigorous way for those patients who experience pain during their cesarean section after the baby is out.
The EAGLET-CS Pilot is a randomized trial that will assess the feasibility of comparing two commonly used approaches to care for women undergoing cesarean delivery under standard neuraxial anesthesia (epidural, spinal, or CSE) who experience intraoperative pain after delivery that is refractory to first line treatments. 12 patients recruited from the labor and delivery service at the Hospital of the University of Pennsylvania will be assigned to one of two standard-care comparators, namely early conversion to general anesthesia versus a time-limited trial of intravenous sedation, followed by conversion to general anesthesia if needed due to ongoing pain. Patients will be assessed during hospitalization and at up to 6 weeks after delivery to assess mental health, medical, and quality of recovery outcomes.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| General anesthesia | Active comparator | Other: General anesthetic | Comparator 1: Standard-care general anesthesia: medically induced unconsciousness with breathing tube placement. |
| Intravenous sedation | Active comparator | Other: Intravenous anesthetic | Comparator 2: Time-limited trial of standard care minimal-to-moderate intravenous sedation, with conversion to general anesthesia if pain persists. |
Sex: Female, ages: 18 Years to any
Inclusion Criteria: * Women aged 18 or older undergoing non-emergent cesarean delivery with primary neuraxial (epidural, spinal, or CSE) anesthesia. Eligible patients will be those who report severe pain during surgery, defined as pain that does not resolve with 2 trials of first-line pharmacologic therapies (e.g., epidural supplementation with local anesthetics; intravenous opioid analgesics). Exclusion Criteria: * We will exclude patients who require induction of general anesthesia prior to umbilical cord clamping and by clinician determination.
| Facility | City | Country | Status |
|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia, Pennsylvania | United States | Recruiting |